| Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment X Ma, E Bi, Y Lu, P Su, C Huang, L Liu, Q Wang, M Yang, MF Kalady, ... Cell metabolism 30 (1), 143-156. e5, 2019 | 706 | 2019 |
| CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability X Ma, L Xiao, L Liu, L Ye, P Su, E Bi, Q Wang, M Yang, J Qian, Q Yi Cell metabolism 33 (5), 1001-1012. e5, 2021 | 615 | 2021 |
| Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages JQQY Pan Su, Qiang Wang, Enguang Bi, Xingzhe Ma, Lintao Liu, Maojie Yang Cancer Research, 2020 | 353 | 2020 |
| The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination F Yu, S Sharma, D Jankovic, RK Gurram, P Su, G Hu, R Li, S Rieder, ... Journal of Experimental Medicine 215 (7), 1813-1821, 2018 | 123 | 2018 |
| Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9 L Liu, E Bi, X Ma, W Xiong, J Qian, L Ye, P Su, Q Wang, L Xiao, M Yang, ... Nature communications 11 (1), 5902, 2020 | 78 | 2020 |
| IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity L Xiao, X Ma, L Ye, P Su, W Xiong, E Bi, Q Wang, M Xian, M Yang, J Qian, ... The Journal of Clinical Investigation 132 (7), 2022 | 60 | 2022 |
| Extracellular matrix protein 1 promotes follicular helper T cell differentiation and antibody production L He, W Gu, M Wang, X Chang, X Sun, Y Zhang, X Lin, C Yan, W Fan, ... Proceedings of the National Academy of Sciences 115 (34), 8621-8626, 2018 | 51 | 2018 |
| MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma Q Wang, D Zhao, M Xian, Z Wang, E Bi, P Su, J Qian, X Ma, M Yang, L Liu, ... Blood, The Journal of the American Society of Hematology 136 (22), 2557-2573, 2020 | 43 | 2020 |
| Novel function of extracellular matrix protein 1 in suppressing Th17 cell development in experimental autoimmune encephalomyelitis P Su, S Chen, YH Zheng, HY Zhou, CH Yan, F Yu, YG Zhang, L He, ... The Journal of Immunology 197 (4), 1054-1064, 2016 | 36 | 2016 |
| E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs E Bi, R Li, LC Bover, H Li, P Su, X Ma, C Huang, Q Wang, L Liu, M Yang, ... The Journal of clinical investigation 128 (11), 4821-4831, 2018 | 35 | 2018 |
| RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway Q Wang, Z Lin, Z Wang, L Ye, M Xian, L Xiao, P Su, E Bi, Y Huang, J Qian, ... Blood, The Journal of the American Society of Hematology 139 (1), 59-72, 2022 | 15 | 2022 |
| Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis M Xian, Q Wang, L Xiao, L Zhong, W Xiong, L Ye, P Su, C Zhang, Y Li, ... Nature communications 15 (1), 5767, 2024 | 8 | 2024 |
| A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors P Su, L Xiao, L Ye, Z Wang, W Xiong, Q Wang, X Ma, M Xian, M Yang, ... Journal of Hematology & Oncology 15 (1), 55, 2022 | 6 | 2022 |
| Correction: enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages P Su, Q Wang, E Bi, X Ma, L Liu, M Yang, J Qian, Q Yi Cancer Research 82 (5), 945-945, 2022 | 4 | 2022 |
| Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers J Qian, Q Wang, L Xiao, W Xiong, M Xian, P Su, M Yang, C Zhang, Y Li, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | 1 | 2024 |
| Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies J Qian, Q Wang, L Liu, E Bi, X Ma, P Su, M Yang, Q Yi Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 1 | 2019 |
| MIF acting as a chaperone of SOD1 mediates MM cell intrinsic resistance to carfilzomib by modulating ROS-induced mitochondrial dysfunction Q Wang, P Su, Q Yi Clinical Lymphoma, Myeloma and Leukemia 19 (10), e140, 2019 | 1 | 2019 |
Qing YiHouston Methodist Cancer Center在 houstonmethodist.org 的电子邮件经过验证